Ryan Trasolini
CIK: 0002135704
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Trasolini Ryan
Trasolini Ryan (SEC CIK 0002135704) files insider reports with the SEC as Co-Chief Executive Officer of Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
Signal8 holds 1 ownership filing by Trasolini Ryan, a Form 3, filed on Jun 1, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Trasolini Ryan's filings is in GAITHERSBURG, MD.
Other insiders filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- HRT FINANCIAL LP, 10% Owner
- Liang Yuying, Chief Financial Officer
- Liriano Angel, Director
- Pathigoda Arachchige Sachin Eranga, Director
- Chambers Adam V, Director
- Richards Steven M, Director